FDA-Device2022-09-07Class II
AggreGuide A-100 Instrument
Aggredyne, Inc.
Hazard
The firm identified a software design issue where the improper shut down of the instrument resulted in speeds.csv file contents of the software version 5.1 being erased. Due to this issue, the target RPM for the assay is 0 and the motor output required to achieve this RPM is also 0. Therefore, when the assay is run, the software applies 0 Volts to the motor and performs a 0 RPM assay. Because of this, there is no mixing of the blood with agonist and no moving of aggregates happens in front of the optical detectors. The resulting PAI is 0 and the result is displayed as Low.
Sold states
International distribution to the country of South Korea.
Affected count
47
Manufactured in
10530 Rockley Rd Ste 150, Houston, TX, United States
Products
AggreGuide A-100 Instrument
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1639-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief